[Endocrine consequences of hemochromatosis]

Area of Science:

• Endocrinology
• Hepatology
• Genetics

Background:

• Hemochromatosis is a condition of iron overload.
• Endocrine complications, primarily diabetes mellitus and hypogonadotrophic hypogonadism, are common in advanced hemochromatosis, often linked with cirrhosis.
• Other endocrine disorders are rare and associated with severe, early iron overload.

Purpose of the Study:

• To review the endocrine complications of hemochromatosis.
• To discuss diagnostic strategies and management, particularly the role of phlebotomy.
• To emphasize considering primary hemochromatosis in hypogonadotrophic hypogonadism.

Main Methods:

• Literature review of endocrine complications in hemochromatosis.
• Analysis of diagnostic criteria for iron overload testing.
• Discussion of therapeutic implications, focusing on phlebotomy.

Main Results:

• Diabetes mellitus and hypogonadotrophic hypogonadism are the most frequent endocrine issues.
• Routine HFE mutation testing is not advised for all type 2 diabetes patients.
• Iron overload testing is recommended for atypical diabetes, hypogonadism, pigmentation, or cirrhosis.

Conclusions:

• Endocrine complications signify advanced hemochromatosis and often cirrhosis.
• Early detection and phlebotomy are crucial for managing these complications.
• Primary hemochromatosis should be a consideration in all hypogonadotrophic hypogonadism cases.